Supplementation of α-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes

Nutrition

Volumn 31, Issue 6, 2015, Pages 853-857

  Gomes, Patricia M ^a   Hollanda Miranda, Wallace R ^a   Beraldo, Rebeca A ^a   Castro, Ana V B ^a   Geloneze, Bruno ^b   Foss, Milton C ^a   Foss Freitas, Maria C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Adiponectin; Hyperinsulinemic euglycemic clamp; Insulin resistance; Type 2 diabetes mellitus; Linolenic acid

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ADIPOQ PROTEIN, HUMAN; ANTIDIABETIC AGENT; EDIBLE OIL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FAT FREE MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HIP CIRCUMFERENCE; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; ADULT; BLOOD; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; ADULT; ALPHA-LINOLENIC ACID; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 84928554528     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.12.028     Document Type: Article

References (26)

1. Ramel A., Martinéz A., Kiely M., Morais G., Bandarra N.M., Thorsdottir I. Beneficial effects of long chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overwheight and obese European young adults. Diabetologia 2008, 51:1261-1268.
2. Brunner E.J., Kivimäki M., Witte D.R., Lawlor D.A., Davey Smith G., Cooper J.A., et al. Inflammation, insulin resistance, and diabetes-Mendelian randomization using CRP haplotypes points upstream. PLoS Med 2008, 5:3369-3977.
3. Gómez J.M., Vila R., Catalina P., Soler J., Badimón L., Sahún M. The markers of inflammation and endothelial dysfunction in correlation with glycated hemoglobin are present in type 2 diabetes mellitus patients but not in their relatives. Glycoconj J 2008, 25:573-579.
4. Saedisomeolia A., Wood L.D., Garg M.L., Gibson P.G., Wark P.A. Antiinflamatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells. Br J Nutr 2009, 101:533-540.
5. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R. Adiponectin: more than just another fat cell hormone?. Diab Care 2003, 26:2442-2450.
6. Meyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
7. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 Suppl):1505-1519.
8. Kromann N., Green A. Epidemiologic studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950 to 1974. Acta Med Scand 1980, 208:401-406.
9. Rizos E.C., Ntzani E.E., Bika E., Kostapanos M.S., Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. JAMA 2012, 308:1024-1033.
10. Burdge G.C., Calder P.C. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005, 45:581-597.
11. Marangoni F., Poli A. n-3 fatty acids: functional differences between food intake, oral supplementation and drug treatments. Int J Cardiol 2013, 170:12-15.
12. Kim K.B., Nam Y.A., Kim H.S., Hayes A.W., Lee B.M. α-Linolenic acid: nutraceutical, pharmacologic and toxicologic evaluation. Food Chem Toxicol 2014, 70C:163-178.
13. Geloneze B., Rodovalho-Geloneze S., Parisi C., Pícolo M., Repetto E.M., Tambascia M.A. Standardization of insulin tolerance test in Brazilian population. Diabetes Res Clin Pract 2000, 50(Suppl 1):S102.
14. Stern S.E., Williams K., Ferrannini E., DeFronzo R.A., Bogardus C., Stern M.P. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005, 54:333-340.
15. Geloneze B., Vasques A.C.J., Stabe C.F.C., Pareja J.C., Rosado L.E.F.P.L., Queiroz E.C., et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome-Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metab 2009, 53:281-287.
16. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp tecgnique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:214-223.
17. Ferrannini E., Mari A. How to measure insulin sensitivity. J Hypertens 1998, 16:895-906.
18. Millis S.R. Emerging standards in statistical practice: implications for clinical trials in rehabilitation medicine. Am J Phys Med Rehabil 2003, 82(10 Suppl):S32-S37.
19. Jacques-Camarena O., González-Ortiz M., Martínez-Abundis E., López-Madrueño J.F.P., Medina-Santillán R. Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance. Ann Nutr Metab 2008, 53:195-198.
20. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 1991, 40:280-289.
21. Taouis M., Dagou C., Ster C., Durand G., Pinault M., Delarue J. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am J Physiol Endocrinol Metab 2002, 282:664-671.
22. Barceló-Coblijn G., Murphy E.J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 2009, 48:355-374.
23. Schuchardt J.P., Hahn A. Bioavailability of long-chain omega-3 fatty acids. PLEFA 2013, 89:1-8.
24. McManus R.M., Jumpson J., Finegood D.T., Clandinin M.T., Ryan E.A. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 1996, 19:463-467.
25. Borkman M., Chisholm D.J., Furler S.M., Storlien L.H., Kraegen E.W., Simons L.A., et al. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 1989, 38:1314-1319.
26. Itoh M., Suganami T., Satoh N., Tanimoto-Koyama K., Yuan X., Tanaka M., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 2007, 27:1918-1925.